Advertisement
Screener

REPLIGEN CORP (RGEN) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

REPLIGEN CORP Increase (Decrease) in Accounts Receivable

REPLIGEN CORP (RGEN) reported Increase (Decrease) in Accounts Receivable of $4.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-29

  • REPLIGEN CORP increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $7.55M, a 44.13% increase year-over-year.
  • REPLIGEN CORP increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$3.19M, a 132.11% decline year-over-year.
  • REPLIGEN CORP increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $9.86M, a 4.93% increase year-over-year.
  • REPLIGEN CORP increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$7.86M, a 332.01% decline year-over-year.
  • REPLIGEN CORP increase (decrease) in accounts receivable for fiscal 2025 was $17.16M, a 22.34% increase from fiscal 2024.
  • REPLIGEN CORP increase (decrease) in accounts receivable for fiscal 2024 was $14.03M, a 323.64% increase from fiscal 2023.
  • REPLIGEN CORP increase (decrease) in accounts receivable for fiscal 2023 was $3.31M, a 7.90% decline from fiscal 2022.
  • REPLIGEN CORP increase (decrease) in accounts receivable for fiscal 2022 was $3.60M, a 92.27% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 3 month as first filedIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 6 month as first filedIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 9 month as first filedIncrease (Decrease) in Accounts Receivable 12 monthIncrease (Decrease) in Accounts Receivable 12 month as first filed
2026-06-30$7.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$4.36M
10-Q · filed 2026-07-29
$14.22M
derived: sum of 3 quarters · filed 2026-07-29
$6.37M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31-$3.19M
10-Q · filed 2026-05-06
$6.68M
derived: sum of 2 quarters · filed 2026-05-06
-$1.18M
derived: sum of 3 quarters · filed 2026-05-06
$4.06M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$9.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$2.01M
derived: sum of 2 quarters · filed 2026-02-26
$7.24M
derived: sum of 3 quarters · filed 2026-07-29
$17.16M
10-K · filed 2026-02-26
2025-09-30-$7.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
-$2.62M
derived: sum of 2 quarters · filed 2026-07-29
$7.30M
10-Q · filed 2025-11-04
$16.70M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$5.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$15.16M
10-Q · filed 2026-07-29
$24.56M
derived: sum of 3 quarters · filed 2026-07-29
$27.94M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$9.92M
10-Q · filed 2026-05-06
$19.32M
derived: sum of 2 quarters · filed 2026-05-06
$22.71M
derived: sum of 3 quarters · filed 2026-05-06
$30.61M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$9.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$12.79M
derived: sum of 2 quarters · filed 2026-02-26
$20.68M
derived: sum of 3 quarters · filed 2026-02-26
$14.03M
10-K · filed 2026-02-26
2024-09-30$3.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$11.28M
derived: sum of 2 quarters · filed 2025-11-04
$4.63M
10-Q · filed 2025-11-04
$16.26M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$7.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$1.25M
10-Q · filed 2025-08-07
$12.87M
derived: sum of 3 quarters · filed 2026-02-26
-$49.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$6.65M
10-Q · filed 2025-04-29
$4.97M
derived: sum of 2 quarters · filed 2026-02-26
-$7.95M
derived: sum of 3 quarters · filed 2026-02-26
-$20.17M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$11.63M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26
-$1.29M
derived: sum of 2 quarters · filed 2026-02-26
-$13.52M
derived: sum of 3 quarters · filed 2026-02-26
$3.31M
10-K · filed 2026-02-26
2023-09-30-$12.92M
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18
-$25.15M
derived: sum of 2 quarters · filed 2024-11-18
-$8.31M
10-Q/A · filed 2024-11-18
-$13.33M
derived: sum of 4 quarters · filed 2025-03-14
2023-06-30-$12.23M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18
$4.61M
10-Q/A · filed 2024-11-18
-$407.00K
derived: sum of 3 quarters · filed 2025-03-14
-$231.00K
derived: sum of 4 quarters · filed 2025-03-14
2023-03-31$16.83M
10-Q/A · filed 2024-11-18
$11.82M
derived: sum of 2 quarters · filed 2025-03-14
$11.99M
derived: sum of 3 quarters · filed 2025-03-14
$14.16M
derived: sum of 4 quarters · filed 2025-03-14
2022-12-31-$5.01M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14
-$4.84M
derived: sum of 2 quarters · filed 2025-03-14
-$2.67M
derived: sum of 3 quarters · filed 2025-03-14
$3.60M
10-K · filed 2025-03-14
2022-09-30$176.00K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18
$2.34M
derived: sum of 2 quarters · filed 2024-11-18
$8.61M
10-Q/A · filed 2024-11-18
$3.21M
derived: sum of 4 quarters · filed 2024-11-18
2022-06-30$2.16M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18
$8.43M
10-Q/A · filed 2024-11-18
$3.03M
derived: sum of 3 quarters · filed 2024-11-18
$23.02M
derived: sum of 4 quarters · filed 2024-11-18
2022-03-31$6.27M
10-Q/A · filed 2024-11-18
$865.00K
derived: sum of 2 quarters · filed 2024-11-18
$20.85M
derived: sum of 3 quarters · filed 2024-11-18
$33.01M
derived: sum of 4 quarters · filed 2024-11-18
2021-12-31-$5.40M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18
$14.58M
derived: sum of 2 quarters · filed 2024-11-18
$26.74M
derived: sum of 3 quarters · filed 2024-11-18
$46.52M
10-K/A · filed 2024-11-18
2021-09-30$19.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
$32.15M
derived: sum of 2 quarters · filed 2022-11-01
$51.93M
10-Q · filed 2022-11-01
$61.46M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$12.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$31.94M
10-Q · filed 2022-08-02
$41.47M
derived: sum of 3 quarters · filed 2023-02-22
$47.00M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$19.78M
10-Q · filed 2022-04-27
$29.31M
derived: sum of 2 quarters · filed 2023-02-22
$34.84M
derived: sum of 3 quarters · filed 2023-02-22
$38.42M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$9.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$15.06M
derived: sum of 2 quarters · filed 2023-02-22
$18.64M
derived: sum of 3 quarters · filed 2023-02-22
$20.89M
10-K · filed 2023-02-22
$21.02M
10-K · filed 2021-02-24
2020-09-30$5.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
$9.11M
derived: sum of 2 quarters · filed 2021-10-28
$11.36M
10-Q · filed 2021-10-28
$11.52M
10-Q · filed 2020-11-05
$12.45M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-30$3.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27
$5.83M
10-Q · filed 2021-07-27
$6.01M
10-Q · filed 2020-07-30
$6.92M
derived: sum of 3 quarters · filed 2022-02-17
$6.34M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-31$2.25M
10-Q · filed 2021-05-04
$2.40M
10-Q · filed 2020-05-06
$3.35M
derived: sum of 2 quarters · filed 2022-02-17
$2.76M
derived: sum of 3 quarters · filed 2022-02-17
$3.39M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-31$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
$513.00K
derived: sum of 2 quarters · filed 2022-02-17
$1.14M
derived: sum of 3 quarters · filed 2022-02-17
$7.83M
10-K · filed 2022-02-17
$7.73M
10-K · filed 2020-02-26
2019-09-30-$583.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$42.00K
derived: sum of 2 quarters · filed 2020-11-05
$6.73M
10-Q · filed 2020-11-05
$11.25M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$625.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$7.32M
10-Q · filed 2020-07-30
$11.84M
derived: sum of 3 quarters · filed 2021-02-24
$8.63M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$6.69M
10-Q · filed 2020-05-06
$11.21M
derived: sum of 2 quarters · filed 2021-02-24
$8.01M
derived: sum of 3 quarters · filed 2021-02-24
$11.26M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$4.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$1.31M
derived: sum of 2 quarters · filed 2021-02-24
$4.57M
derived: sum of 3 quarters · filed 2021-02-24
$6.10M
10-K · filed 2021-02-24
2018-09-30-$3.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$54.00K
derived: sum of 2 quarters · filed 2019-10-31
$1.58M
10-Q · filed 2019-10-31
-$1.00K
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$3.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$4.79M
10-Q · filed 2019-08-01
$3.20M
derived: sum of 3 quarters · filed 2020-02-26
$5.33M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31$1.53M
10-Q · filed 2019-05-09
-$55.00K
derived: sum of 2 quarters · filed 2020-02-26
$2.07M
derived: sum of 3 quarters · filed 2020-02-26
$6.00M
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31-$1.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
$541.00K
derived: sum of 2 quarters · filed 2020-02-26
$4.47M
derived: sum of 3 quarters · filed 2020-02-26
$6.89M
10-K · filed 2020-02-26
2017-09-30$2.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$6.06M
derived: sum of 2 quarters · filed 2018-11-01
$8.47M
10-Q · filed 2018-11-01
$8.42M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$3.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$6.35M
10-Q · filed 2018-08-02
$6.30M
derived: sum of 3 quarters · filed 2019-03-01
$10.46M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$2.42M
10-Q · filed 2018-05-08
$2.37M
derived: sum of 2 quarters · filed 2019-03-01
$6.53M
derived: sum of 3 quarters · filed 2019-03-01
$4.49M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$48.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$4.11M
derived: sum of 2 quarters · filed 2019-03-01
$2.07M
derived: sum of 3 quarters · filed 2019-03-01
$3.22M
10-K · filed 2019-03-01
2016-09-30$4.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$2.12M
derived: sum of 2 quarters · filed 2017-11-09
$3.27M
10-Q · filed 2017-11-09
$4.24M
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30-$2.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
-$892.00K
10-Q · filed 2017-08-03
$81.00K
derived: sum of 3 quarters · filed 2018-02-22
-$3.98M
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31$1.15M
10-Q · filed 2017-05-04
$2.12M
derived: sum of 2 quarters · filed 2018-02-22
-$1.94M
derived: sum of 3 quarters · filed 2018-02-22
-$2.36M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$973.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
-$3.09M
derived: sum of 2 quarters · filed 2018-02-22
-$3.51M
derived: sum of 3 quarters · filed 2018-02-22
$3.73M
10-K · filed 2018-02-22
2015-09-30-$4.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$4.48M
derived: sum of 2 quarters · filed 2016-11-03
$2.76M
10-Q · filed 2016-11-03
$2.77M
10-Q · filed 2015-11-05
$3.59M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-30-$417.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$6.82M
10-Q · filed 2016-08-04
$6.85M
10-Q · filed 2015-08-06
$7.65M
derived: sum of 3 quarters · filed 2017-02-23
$5.87M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-31$7.24M
10-Q · filed 2016-05-05
$7.24M
10-Q · filed 2015-05-08
$8.07M
derived: sum of 2 quarters · filed 2017-02-23
$6.29M
derived: sum of 3 quarters · filed 2017-02-23
$8.74M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$834.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
-$950.82K
derived: sum of 2 quarters · filed 2017-02-23
$1.50M
derived: sum of 3 quarters · filed 2017-02-23
$1.60M
10-K · filed 2017-02-23
$1.60M
10-K · filed 2015-03-17
2014-09-30-$1.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$668.94K
derived: sum of 2 quarters · filed 2015-11-05
$763.00K
10-Q · filed 2015-11-05
$762.77K
10-Q · filed 2014-11-07
-$581.95K
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$2.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$2.55M
10-Q · filed 2015-08-06
$1.20M
derived: sum of 3 quarters · filed 2016-02-25
$2.51M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$94.06K
10-Q · filed 2015-05-08
-$1.25M
derived: sum of 2 quarters · filed 2016-02-25
$53.23K
derived: sum of 3 quarters · filed 2016-02-25
-$1.90M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31-$1.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
-$40.84K
derived: sum of 2 quarters · filed 2016-02-25
-$2.00M
derived: sum of 3 quarters · filed 2016-02-25
$774.00K
10-K · filed 2016-02-25
$773.95K
10-K · filed 2014-03-14
2013-09-30$1.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
-$653.22K
derived: sum of 2 quarters · filed 2014-11-07
$2.12M
10-Q · filed 2014-11-07
-$1.34M
derived: sum of 4 quarters · filed 2015-03-17
2013-06-30-$1.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$814.84K
10-Q · filed 2014-08-11
-$2.65M
derived: sum of 3 quarters · filed 2015-03-17
-$3.12M
derived: sum of 4 quarters · filed 2015-03-17
2013-03-31$2.77M
10-Q · filed 2014-05-09
-$688.83K
derived: sum of 2 quarters · filed 2015-03-17
-$1.16M
derived: sum of 3 quarters · filed 2015-03-17
$2.62M
derived: sum of 4 quarters · filed 2015-03-17
2012-12-31-$3.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17
-$3.93M
derived: sum of 2 quarters · filed 2015-03-17
-$150.74K
derived: sum of 3 quarters · filed 2015-03-17
$1.21M
10-K · filed 2015-03-17
2012-09-30-$469.55K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$3.31M
derived: sum of 2 quarters · filed 2013-11-08
$4.67M
10-Q · filed 2013-11-08
-$1.64M
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$3.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
$5.14M
10-Q · filed 2013-08-07
-$1.17M
derived: sum of 3 quarters · filed 2014-03-14
$327.72K
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31$1.36M
10-Q · filed 2013-05-07
-$4.95M
derived: sum of 2 quarters · filed 2014-03-14
-$3.45M
derived: sum of 3 quarters · filed 2014-03-14
-$2.19M
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31-$6.31M
derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14
-$4.81M
derived: sum of 2 quarters · filed 2014-03-14
-$3.55M
10-K · filed 2014-03-14
-$3.46M
derived: sum of 4 quarters · filed 2014-03-14
2011-09-30$1.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09
$2.76M
10-Q · filed 2011-11-09
$2.85M
10-Q · filed 2012-11-08
$1.92M
derived: sum of 4 quarters · filed 2014-03-14
2011-06-30$1.26M
10-Q · filed 2011-08-05
$1.35M
10-Q · filed 2012-08-09
$425.81K
derived: sum of 3 quarters · filed 2014-03-14
$983.57K
derived: sum of 4 quarters · filed 2014-03-14
2011-03-31$88.43K
10-Q · filed 2012-05-10
-$836.40K
derived: sum of 2 quarters · filed 2014-03-14
-$278.64K
derived: sum of 3 quarters · filed 2014-03-14
$689.57K
10-K · filed 2013-03-15
2010-12-31-$924.83K
derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14
-$367.06K
derived: sum of 2 quarters · filed 2014-03-14
$601.14K
10-K · filed 2014-03-14
2010-09-30$557.77K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09
$1.53M
10-Q · filed 2011-11-09
2010-06-30$968.21K
10-Q · filed 2011-08-05
2010-03-31$29.26K
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78